Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

SAREPTA THERAPEUTICS, INC.

Filed by SAREPTA THERAPEUTICS, INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-11-06 06:26:26 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 19, 2026
Income
Not reported
Expenses
$160,000.00
Filing UUID
dafeff09-242c-422b-bd8c-9a9bd0ab96be
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

H.R. 9260 - LHHS Appropriations

Literal federal measure citations: H.R. 9260

HCR · Health Issues

Rare Pediatric Disease Priority Review Voucher (PRV) Program Issues related to patient access to treatment

SCI · Science/Technology

National Security Commission on emerging biotechnology policy proposals

TRD · Trade (domestic/foreign)

Issues related to Section 232

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.